Table 2.

 Treatment outcomes according to the duration of doxycycline

Treatment outcomes	No. of patients (%)		P‐values†
	3‐week doxycycline (n = 12)	6‐week doxycycline (n = 26)
Presentation of tumors
Conjunctival	9 (75)	21 (81)	0.685
Non‐conjunctival	3 (25)	5 (19)
Best response
CR	2 (17)	5 (19)	0.239
PR	2 (17)	9 (35)
SDz	8 (66)	12 (46)
Time to response
Median, months	10.7	3.3	0.189
Range	3.3–30.3	1.2–23.3
Progression
No	11 (92)	22 (85)	0.550
Yes	1 (8)	4 (15)
2‐year TTF	89%	82%	0.882

†Pearson’s chi‐square or Fisher’s exact test. CR, complete remission; PR, partial remission; SDz, stable disease; TTF, time‐to‐treatment failure.